Published in Circ Res on February 18, 2010
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization. Vasc Health Risk Manag (2010) 1.16
Bomb Pulse Biology. Nucl Instrum Methods Phys Res B (2012) 0.93
Carotid plaque age is a feature of plaque stability inversely related to levels of plasma insulin. PLoS One (2011) 0.83
Bomb-pulse 14C analysis combined with 13C and 15N measurements in blood serum from residents of Malmö, Sweden. Radiat Environ Biophys (2013) 0.79
14C BOMB-PULSE DATING AND STABLE ISOTOPE ANALYSIS FOR GROWTH RATE AND DIETARY INFORMATION IN BREAST CANCER? Radiat Prot Dosimetry (2016) 0.75
Cold war battle against hot atherosclerotic plaques. Circ Res (2010) 0.75
Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol (2004) 2.41
Expressed sequence tag-linked microsatellites as a source of gene-associated polymorphisms for detecting signatures of divergent selection in atlantic salmon (Salmo salar L.). Mol Biol Evol (2005) 1.77
Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice. J Am Coll Cardiol (2007) 1.77
Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in Rag-1 knockout mice. Arterioscler Thromb Vasc Biol (2002) 1.59
HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2003) 1.48
Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet (2012) 1.40
Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.31
Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism (2004) 1.26
A software tool for increased efficiency in observer performance studies in radiology. Radiat Prot Dosimetry (2005) 1.25
Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation (2004) 1.19
Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler Thromb Vasc Biol (2003) 1.19
Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation. Arterioscler Thromb Vasc Biol (2012) 1.17
Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol Med (2012) 1.16
Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia. PLoS One (2010) 1.13
Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia. Arterioscler Thromb Vasc Biol (2009) 1.08
Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease. Arterioscler Thromb Vasc Biol (2003) 1.08
Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arterioscler Thromb Vasc Biol (2012) 1.07
Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2012) 1.06
Household salt as a retrospective dosemeter using optically stimulated luminescence. Radiat Environ Biophys (2008) 1.04
Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence. Atherosclerosis (2012) 1.03
Breast compression in mammography: pressure distribution patterns. Acta Radiol (2012) 1.02
CRP--marker or maker of cardiovascular disease? Arterioscler Thromb Vasc Biol (2005) 1.02
Accelerator mass spectrometry. Mass Spectrom Rev (2008) 1.02
Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2005) 1.02
T cell modulation of intimal thickening after vascular injury: the bimodal role of IFN-gamma in immune deficiency. Arterioscler Thromb Vasc Biol (2005) 1.00
CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice. BMC Immunol (2010) 1.00
FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice. J Immunol (2010) 1.00
T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. Arterioscler Thromb Vasc Biol (2013) 0.98
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction. Eur Heart J (2008) 0.98
Vaccination against atherosclerosis? Induction of atheroprotective immunity. Semin Immunopathol (2009) 0.97
Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression. Autoimmunity (2005) 0.97
Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochem Biophys Res Commun (2008) 0.96
Accuracy of the quantification of organ activity from planar gamma camera images. Cancer Biother Radiopharm (2003) 0.96
Perilipin and adipophilin expression in lipid loaded macrophages. Biochem Biophys Res Commun (2007) 0.94
Nodule detection in digital chest radiography: summary of the RADIUS chest trial. Radiat Prot Dosimetry (2005) 0.94
Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events. Atherosclerosis (2007) 0.94
Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque. Stroke (2012) 0.94
Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells. BMC Immunol (2008) 0.94
Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques. Stroke (2003) 0.93
Development of a diet quality index assessing adherence to the Swedish nutrition recommendations and dietary guidelines in the Malmö Diet and Cancer cohort. Public Health Nutr (2011) 0.93
The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling. Cardiovasc Res (2011) 0.92
Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. J Biol Chem (2001) 0.91
Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease. Stroke (2007) 0.91
Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages. Lipids Health Dis (2006) 0.91
Lymphocytes in atherosclerosis. Clin Chim Acta (2012) 0.90
Activation of calpain-1 in human carotid artery atherosclerotic lesions. BMC Cardiovasc Disord (2009) 0.90
Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals. Arterioscler Thromb Vasc Biol (2013) 0.89
High disaccharide intake associates with atherogenic lipoprotein profile. Br J Nutr (2011) 0.89
A high diet quality is associated with lower incidence of cardiovascular events in the Malmö diet and cancer cohort. PLoS One (2013) 0.89
B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10. Thromb Haemost (2015) 0.89
Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation (2011) 0.88
Real-time optical-fibre luminescence dosimetry for radiotherapy: physical characteristics and applications in photon beams. Phys Med Biol (2004) 0.88
Alternate trains of postural muscle vibration promote cyclic body displacement in standing parkinsonian patients. Mov Disord (2008) 0.87
Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100. Atherosclerosis (2006) 0.87
Nodule detection in digital chest radiography: introduction to the RADIUS chest trial. Radiat Prot Dosimetry (2005) 0.87
Shortened life span, bradycardia, and hypotension in mice with targeted expression of an Igf2 transgene in smooth muscle cells. Endocrinology (2003) 0.87
Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells. Circ Res (2009) 0.87
Very low-density lipoprotein induces interleukin-1beta expression in macrophages. Biochem Biophys Res Commun (2005) 0.86
Cystatin C and cathepsins in cardiovascular disease. Front Biosci (2008) 0.86
Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaques. Cardiovasc Pathol (2013) 0.86
Will autoantibodies help to determine severity and progression of atherosclerosis? Curr Opin Lipidol (2004) 0.85
Autoantibodies against modified low-density lipoproteins in coronary artery disease. Atherosclerosis (2003) 0.85
TAP1-deficiency does not alter atherosclerosis development in Apoe-/- mice. PLoS One (2012) 0.85
Simvastatin stimulates macrophage interleukin-1beta secretion through an isoprenylation-dependent mechanism. Vascul Pharmacol (2006) 0.85
Optimizing a readout protocol for low dose retrospective OSL-dosimetry using household salt. Health Phys (2012) 0.85
Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice. PLoS One (2013) 0.84
Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis. Cardiovasc Res (2011) 0.84
Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice. Atherosclerosis (2005) 0.84
Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury. Circ Res (2007) 0.84
Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice. Biochem Biophys Res Commun (2005) 0.83
Comparative measurements of the external radiation exposure in a 137Cs contaminated village in Belarus based on optically stimulated luminescence in NaCl and thermoluminescence in LiF. Health Phys (2012) 0.83
Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol (2012) 0.83
Evaluation of image quality of lumbar spine images: a comparison between FFE and VGA. Radiat Prot Dosimetry (2005) 0.83
A compartmental model for biokinetics and dosimetry of 18F-choline in prostate cancer patients. J Nucl Med (2012) 0.83
Screen for Footprints of Selection during Domestication/Captive Breeding of Atlantic Salmon. Comp Funct Genomics (2012) 0.83
Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappaB activation. Metabolism (2002) 0.83
Elastin and calcium rather than collagen or lipid content are associated with echogenicity of human carotid plaques. Stroke (2004) 0.83
Retrospective dosimetry using OSL of tooth enamel and dental repair materials irradiated under wet and dry conditions. Radiat Environ Biophys (2012) 0.83
Lead in finger bone, whole blood, plasma and urine in lead-smelter workers: extended exposure range. Int Arch Occup Environ Health (2005) 0.83
Arm weight support training improves functional motor outcome and movement smoothness after stroke. Funct Neurol (2014) 0.82
Medical imaging for improved tumour characterization, delineation and treatment verification. Acta Oncol (2002) 0.82
Timing affects the efficacy of LDL immunization on atherosclerotic lesions in apo E (-/-) mice. Atherosclerosis (2004) 0.82
Sex chromosome polymorphisms in Arctic charr and their evolutionary origins. Genome (2011) 0.82
Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice. Arterioscler Thromb Vasc Biol (2009) 0.81
Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment. J Am Coll Cardiol (2010) 0.81
Insulin-like growth factor II and its receptors in atherosclerosis and in conditions predisposing to atherosclerosis. Curr Opin Lipidol (2003) 0.81
Therapy with radiopharmaceuticals. Acta Oncol (2002) 0.81
Altered AP-1/Ref-1 redox pathway and reduced proliferative response in iNOS-deficient vascular smooth muscle cells. Vasc Med (2004) 0.81
Elastin- and collagen-rich human carotid plaques have increased levels of the cysteine protease inhibitor cystatin C. J Vasc Res (2008) 0.81
Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques. Arterioscler Thromb Vasc Biol (2005) 0.81
Single uptake measurement for absorbed dose planning for radioiodine treatment of hyperthyroidism. Cancer Biother Radiopharm (2003) 0.81
Assessment of the environmental contamination with long-lived radionuclides around an operating RBMK reactor station. J Environ Radioact (2006) 0.80
Ceylon cinnamon does not affect postprandial plasma glucose or insulin in subjects with impaired glucose tolerance. Br J Nutr (2011) 0.80
Immunomodulation of atherosclerosis with a vaccine. Nat Clin Pract Cardiovasc Med (2005) 0.80
Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases. HPB (Oxford) (2013) 0.80
Scoring models of a diet quality index and the predictive capability of mortality in a population-based cohort of Swedish men and women. Public Health Nutr (2012) 0.80